These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 17065025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Splenic marginal zone lymphoma: disease features and management.
    Matutes E.
    Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
    [Abstract] [Full Text] [Related]

  • 4. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Bennett M, Yegena S, Dave HP, Schechter GP.
    Hematol Oncol; 2008 Jun; 26(2):114. PubMed ID: 18271062
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.
    Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J.
    Leuk Lymphoma; 2007 Aug; 48(8):1630-2. PubMed ID: 17701596
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma.
    Koh LP, Lim LC, Thng CH.
    Med Oncol; 2000 Aug; 17(3):225-8. PubMed ID: 10962535
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Schaefer IM, Marx A, Sauer C, Hohloch K, Ghadimi BM, Trümper L, Ströbel P.
    Histopathology; 2013 Mar; 62(4):664-7. PubMed ID: 23379885
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ, Ali S.
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [Abstract] [Full Text] [Related]

  • 18. [Splenic marginal zone lymphoma associated with antiphospholipid antibodies].
    Yokoi T, Mori S, Sugimoto H, Komiyama Y, Uemura Y, Tanijiri R, Nakai K, Matsumoto N, Zen K, Amakawa R, Kishimoto Y, Ieko M, Takahashi H, Fukuhara S.
    Rinsho Ketsueki; 2004 Oct; 45(10):1095-9. PubMed ID: 15553043
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis.
    Hanly JG, Smith SA, Anderson D.
    J Rheumatol; 2003 Sep; 30(9):1990-3. PubMed ID: 12966603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.